4
Changes in Ownership
Aligos Therapeutics, Inc. Filed Acc 0001610717-24-000124
Options or other derivatives
- Chief Medical Officer acquired 72,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| McClure Matthew W. Chief Medical Officer | 2024-03-01 | Grant or award · Stock Option (Right to Buy) | +72,000 | 72,000 | D: show line 1 in the form |
Loading xslF345X05/form4.xml…